A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17.
| Image |  |
|---|---|
| Description | scientific article published on 21 April 2017 |
| Author/s |
author: Ching-yao Yang |
| Publication date | April 21, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |